RecruitingNCT02545478
Biomarkers in Infection
Early Detection of Inflammatory Biomarkers in Infection
Sponsor
Beth Israel Deaconess Medical Center
Enrollment
4,200 participants
Start Date
Apr 1, 2006
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this investigation is to evaluate how early biomarkers of infection and inflammation perform in identifying patients at risk for poor outcome in sepsis and septic shock.
Eligibility
Min Age: 18 Years
Inclusion Criteria8
- Age 18 years of age or older
- Confirmed or suspected infection
- Age 18 years of age or older
- A non-infectious clinical presentation to include
- Normal white blood cell count ( > 4,000 and/or < 12,000)
- Normothermia ( > 96.5 and/or less 100.4)
- Absence of the following clinical complaints: productive cough, fever, pyuria, rash
- No evidence of acute coronary syndrome
Exclusion Criteria1
- \- Suspected infection
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02545478
Related Trials
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
NCT051899251 location
ICU Combined Assessment of Cardio-Respiratory Exercise
NCT061939802 locations
Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis
NCT0333400620 locations
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
NCT0685464020 locations
Smart Discharges for Older Children
NCT076291547 locations